Terray Therapeutics

Terray Therapeutics
Terray Therapeutics has developed a platform for small molecule drug discovery that combines ultra-high throughput experimentation with generative AI, biology, and medicinal chemistry, facilitating the rapid identification of effective small molecules, particularly in immunology. The platform employs advanced automation and nanotechnology to optimize the drug discovery process.
HQ: Pasadena, California, United States
Country: USA

Establishment Year:
2018

Company Stage:
Mature

Estimated Employees:
101 .. 250

Estimated Revenues
$M 18.00

Raised Funding:
$M 200.00

AI Categories: